학술논문
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Document Type
Article
Author
Song, Joon Young; Choi, Won Suk; Heo, Jung Yeon; Lee, Jin Soo; Jung, Dong Sik; Kim, Shin-Woo; Park, Kyung-Hwa; Eom, Joong Sik; Jeong, Su Jin; Lee, Jacob; Kwon, Ki Tae; Choi, Hee Jung; Sohn, Jang Wook; Kim, Young Keun; Noh, Ji Yun; Kim, Woo Joo; Roman, François; Ceregido, Maria Angeles; Solmi, Francesca; Philippot, Agathe; Walls, Alexandra C.; Carter, Lauren; Veesler, David; King, Neil P.; Kim, Hun; Ryu, Ji Hwa; Lee, Su Jeen; Park, Yong Wook; Park, Ho Keun; Cheong, Hee Jin
Source
In eClinicalMedicine September 2022 51
Subject
Language
ISSN
2589-5370